[MARKET ANALYSIS] European bourses slip as AI concerns hit European Banks; US equity futures rebound slightly

European markets are experiencing weakness, particularly in the banking sector, which is dragging down indices like the IBEX 35.

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

[MARKET ANALYSIS] Spot gold retreats from Monday's best as USD strength weighs

China announces that the hot-rolled steel coil issue with South Korea has been resolved

[MARKET ANALYSIS] European bourses slip as AI concerns hit European Banks; US equity futures rebound slightly

Citrini's Jukan posts "A Taiwan-sourced rumor is circulating that NVIDIA’s Vera Rubin could be delayed by 2–4 months due to SK Hynix’s HBM4."

Spain's Treasury says it expects to raise EUR 6bln from its 30-year syndicated bond sale

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • European bourses (STOXX 600 U/C) are broadly weaker, with the IBEX 35 (-0.7%) the clear laggard as Banks weigh on the index. On the other hand, the SMI (+0.4%) is printing modest gains.
  • Sectors, on the contrary, show a positive bias, with Utilities (+1.5%) and Materials (+0.7%) outperforming, helped by the likes of Sika (+2.8%), Givaudan (+2.1%) and Croda (+4.7%). Sika shares are rising this morning as the Board proposes to lift the gross dividend per share by 2.8%. Croda announced its FY25 earnings, with its revenue and EBITDA metrics rising Y/Y and FY26 guidance in line with forecasts. This is helping the broader Chemicals sector rise. On the other hand, Banks (-1.3%) have been hit this morning following weak Q4 earnings by Standard Chartered (-1.3%) and the effects of Anthropic's Claude on jobs as the code can now automate COBOL modernisation efforts.
  • Other key movers include Novo Nordisk (-2.7%), Fresenius Medical Care (-6.5%) and Telefonica (-0.2%). The Danish pharma giant has seen its shares continue to slip as brokers including Kepler Cheuvreux and JPM downgrade the Co. while the former also cuts its PT to DKK 280/shr from DKK 400/shr. Over in Germany, despite positive Q4 earnings, 2026 guidance has sent shares of Fresenius Medical Care lower as the Co. sees flat profit growth. For Spain's Telefonica, the Co. missed analyst's Q4 revenue estimates but growth in Brazil and Spain helped offset losses in other European markets.
  • US equity futures (NQ +0.3%, ES/RTY +0.2%) are modestly rebounding following Monday's selloff, aided by another AI scare. Citrini released a report over the weekend stating that AI may significantly displace workers, with unemployment possibly rising to 10% within 18 months and causing a recession.
Context

Concerns around AI's potential impact on jobs, particularly highlighted by a recent report, are weighing on sentiment, although US equity futures show signs of a mild rebound. The mixed performance suggests sector-specific dynamics are at play, with utilities and materials outperforming amid broader unease.

Related headlines

The whole workspace, free to try.

Try it free